Navigation Links
JAK1 in Medical News

Jefferson researchers uncover new evidence of prolactin's possible role in breast cancer

...al Molecular Endocrinology, identifies the protein jak1 as playing a key part in prolactin signaling in br... cancer. In breast cancer cells, we found that jak1 not only stimulates conventional prolactin signaling via proteins such as Stat5, but also that jak1 recruited new signals, especially Stat3 and ERK, s...
JAK1 in Biological Technology

Efficient Delivery of siRNAs to Human Primary Cells: Electroporation vs. Chemical Transfection

...idated siRNAs targeting CDK2, p53, and jak1 were individually electroporated into t...ee siRNAs (1.33 g) targeting CDK2, p53, jak1 and a scrambled sequence were electropo...s were used to normalize the CDK2, p53, jak1 data. Percent gene expression was calculated as a ...
JAK1 in Biological Products

Rabbit Anti-JAK1, phospho (Tyr1022 / Tyr1023) Polyclonal Antibody, Unconjugated from Abcam

Description:... Rabbit polyclonal to jak1 (phospho Y1022 + Y1023) ( Abpromise for all tested applications). entrezGeneID: 3716 SwissProtID: P23458...
Company:Abcam
JAK1 in other areas

Janus kinase 1 - Wikipedia, the free encyclopedia

JAK1 is essential for signaling for certain type I and type II cytokines. It interacts with the common gamma chain (γc) of type I cytokine receptors, to elicit signals from the IL-2 receptor family, the IL-4 receptor family,...

Jak1 MGI Mouse Gene Detail - MGI:96628 - Janus kinase 1

Mouse Jak1 Chr4:100824972-100937887 bp, - strand has data for genome coordinates, ... Comparative Map (Mouse/Human Jak1 ± 2 cM) ...

Jak1 Rat Gene (Janus kinase 1) - Rat Genome Database

Jak1 (Janus kinase 1) protein-tyrosine kinases; involved in intracellular signal transduction ... Homo sapiens: JAK1 See the Human gene in context in: UCSC ...

Phospho-Jak1 (Tyr1022/1023) Antibody #3331

... Jak/Stat Pathway. Phospho-Jak1 (Tyr1022/1023) Antibody #3331 ... residues 1022/1023 of Jak1 in the putative activation loop ... 3332 Jak1 Antibody ...

Jak1 Blocking Peptide #1013

This peptide is used to block Jak1 (6G4) Rabbit mAb #3344 reactivity. ... Product Pathways - Jak/Stat Pathway. Jak1 Blocking Peptide #1013. pathway. more info ...

Jak1 by Jacob Stockman | Replacements, Ltd

Jak1 by Jacob Stockman - Coin Silver,Pa,1828,Plain,Tipped
Other Tags
(Date:7/27/2014)... Manufacturers of natural ingredient beauty creams are ... a younger appearance. The Cherry News company has published ... and women explore the availabilities from U.S. retailers at ... in the posted guide on the Cherry News website ... drawback to some natural ingredient formulas is the high ...
(Date:7/27/2014)... pill-only antiviral drug regimens could provide shorter, more effective ... of patients infected with hepatitis C, even those most ... studies published in The Lancet . , Both ... the most common genotype in the USA, Europe, North ... most difficult to treat. , Around 150 million people ...
(Date:7/27/2014)... University scientists have shown that a powerful drug given ... only halves the early risk of rejection, but that ... drugs to be used after the operation. , The ... and presented at the World Transplant Congress in San ... difficult transplant conundrum: the powerful combinations of treatments used ...
(Date:7/27/2014)... 27, 2014 The report, “Glass ... Market By Raw Material, By Manufacturing Process, By ... & By Geography – Global Trends & Forecast ... Composites market with an analysis and forecast by ... tables and 107 figures spread through 347 slides ...
(Date:7/27/2014)... 27, 2014 The inaugural Latino ... their passion for protecting our environment and getting outdoors. ... Southwest, will go on hiking or camping outings, participate ... their support for permanently protecting our land, water and ... Latino community’s perspective on the environment like the need ...
Breaking Medicine News(10 mins):Health News:Natural Eye Cream Buyer's Guide Published Online at Consumer News Website 2Health News:The Lancet: New oral drug regimens cure hardest-to-treat hepatitis C 2Health News:The Lancet: New oral drug regimens cure hardest-to-treat hepatitis C 3Health News:Kidney transplant drug halves the early risk of rejection and allows less toxic treatment 2Health News:Kidney transplant drug halves the early risk of rejection and allows less toxic treatment 3Health News:Major Drivers for GFRP Composites Market in Future – Report by MarketsandMarkets 2Health News:Major Drivers for GFRP Composites Market in Future – Report by MarketsandMarkets 3Health News:Major Drivers for GFRP Composites Market in Future – Report by MarketsandMarkets 4Health News:Latino Conservation Action Week Launches, Highlights Latinos’ Dedication to Protecting Our Environment 2Health News:Latino Conservation Action Week Launches, Highlights Latinos’ Dedication to Protecting Our Environment 3
(Date:7/24/2014)... 24, 2014) Scientists at The New York ... step closer to creating a viable cell replacement ... cells. , For the first time, NYSCF ... from skin samples of patients with primary progressive ... protocol to induce these stem cells into becoming ...
(Date:7/24/2014)... - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) ... long-term, randomized, active control Phase 3 study of Zerenex ... binder, for the treatment of hyperphosphatemia in patients with ... (PhosphatE binding and iRon delivery with FErric CiTrate in ... of the American Society of Nephrology ( JASN ...
(Date:7/24/2014)... (July 24, 2014) Scientists at The New ... one step closer to creating a viable cell ... own cells. , For the first time, ... lines from skin samples of patients with primary ... accelerated protocol to induce these stem cells into ...
Breaking Biology News(10 mins):NYSCF scientists one step closer to cell therapy for multiple sclerosis patients 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2
Other Contents